Perioperative cardiovascular complications versus perioperative bleeding in consecutive patients with known cardiac disease undergoing non-cardiac surgery. Focus on antithrombotic medication. The PRAGUE-14 registry
Open Access
- 14 August 2014
- journal article
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 22 (9) , 372-379
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Management of Antiplatelet Therapy inPatients at Risk for Coronary StentThrombosis Undergoing Non-Cardiac SurgeryDrugs, 2011
- Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trialBritish Journal of Anaesthesia, 2011
- Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgeryJournal of Thrombosis and Haemostasis, 2011
- Randomized Controlled Trial of Dual Antiplatelet Therapy in Patients Undergoing Surgery for Critical Limb IschemiaAnnals of Surgery, 2010
- Definition of major bleeding in surgery: an anesthesiologist’s point of view: a rebuttalJournal of Thrombosis and Haemostasis, 2010
- To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trialBritish Journal of Anaesthesia, 2010
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patientsJournal of Thrombosis and Haemostasis, 2009
- Reoperation for Bleeding in Patients Undergoing Coronary Artery Bypass SurgeryCirculation: Cardiovascular Quality and Outcomes, 2009
- Duration of Red-Cell Storage and Complications after Cardiac SurgeryNew England Journal of Medicine, 2008
- Low‐dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta‐analysisJournal of Internal Medicine, 2005